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   (A) UV-induced apoptosis in human B cells proceeds rapidly, as detected 
by annexin V (AxV) staining. Alterations in ICAM-3 levels (detected with mAb 
staining) are closely associated with changes in cell size (as assessed by flow 
cytometry – electronic volume) and occur very early in apoptosis.  (B) Apoptotic 
HeLa cells expressing ICAM-3-GFP (green) reveal ICAM-3 localisation to 
apoptotic bodies. (C) Western blot analysis of EV of apoptotic human B cells (WT: 
ICAM-3-replete, or ICAM-3LOW) demonstrates release of ICAM-3 in acdEV.     
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  Apoptosis culminates in rapid, non-phlogistic removal of cell corpses by 
recruited and resident phagocytes of the innate immune system1-3.  Relatively little 
is known of the molecular mechanisms underlying phagocyte recruitment to sites 
of cell death in vivo.  However defective clearance of dying cells is known to 
contribute to autoimmunity and the development of atherosclerosis1.   
 We have shown previously that ICAM-3 (a human leukocyte-restricted IgSF 
member) acts as a molecular ‘flag’ to mediate corpse removal4,5.  Here we show 
that ICAM-3 on apoptotic cell-derived extracellular vesicles (acdEV) mediates 
phagocyte recruitment. Furthermore we demonstrate that ICAM-3 promotes 
migration to apoptotic foam cells and mediates in vitro transendothelial migration 
of monocytes, suggesting ICAM-3 on acdEV may have a role to play in the 
pathogenesis of atherosclerosis. 
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EV promote monocyte attraction via ICAM-3 
  (A) EV from apoptotic B cells (WT & ICAM-3LOW) were assayed for their 
chemoattractive capacity using Dunn chambers.  WT, but not ICAM-3LOW, EV are 
potent monocyte attractants. This migration is inhibited by anti-ICAM-3 mAb 
(MA4) but not by an isotype control mAb.  Data shown are mean ± SEM (n=3). 
 (B) Representative chemotaxis plots show monocyte migration to acdEV from 
WT B cells or monocytes in the presence or absence of a blocking anti-ICAM-3 
mAb (MA4). The red spot indicates the chemoattractant source and cells begin 
their migration from the blue spot. The plots show a scale of ± 470µm.  
 
  HUVEC cells were grown on 8µm transwells (BD) until a fluid-tight barrier 
was formed.  acdEV from B cells (WT or ICAM-3LOW) or THP-1 monocytes) were 
placed in the lower chamber whilst THP cells stimulated with dihydroxyvitamin D3 
were placed in the upper chamber (A).  Migration of monocytes to the lower 
chamber was assessed using the Cell IQ automated cell tracking system (CM 
Technologies).  Monocytes migrated more quickly towards B cell EV that were 
replete for ICAM-3 (B) and showed strong migration to EVfrom ICAM-3-bearing 
apoptotic THP-1 monocytes (C). 
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 ICAM-3 is shed with acdEV during leukocyte apoptosis. Such acdEV are 
released early in apoptosis and are potent chemoattractants for monocytes. 
 ICAM-3 on acdEV promotes monocyte recruitment to a range of apoptotic 
cells, including lymphocytes and monocytes. ICAM-3 and acdEV are capable of 
recruiting monocytes across an endothelial barrier.   
 CD14, an important phagocyte receptor for apoptotic cells, does not appear 
to be required for phagocyte migration to acdEV. 
 ICAM-3 and CX3CL1 are involved in migration to apoptotic foam cells and 
macrophages respectively.   
 Taken together these data suggest acdEV and ICAM-3 may play an important 
role in the recruitment of macrophages to sites of cell death.  Such sites may 
include tumours and atherosclerotic plaques.  Furthermore, the inhibition of 
monocyte migration in the presence of anti-ICAM-3 mAbs suggests ICAM-3 may 
be a useful target for modulation of monocyte recruitment for therapeutic gain. 
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  EV from apoptotic THP-1-derived macrophages (A) or oxidised LDL-
laden macrophages (foam cells; B) were assessed for their capacity to recruit 
THP-1 monocytes using a horizontal Dunn chemotaxis chamber method.     Data 
shown are mean ± SEM (n>3).  Addition of blocking mAbs to: ICAM-3, CX3CL1 or 
CD14 (an important MØ receptor for apoptotic cells) highlights the importance of 
ICAM-3 in recruitment of phagocytes to apoptotic foam cells. P<0.05. 
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  Using IZON’s Tunable Resistive Pulse Sensing technology (qNano), 
acdEV from human B cells were analysed after depletion of cells and large 
apoptotic bodies by centrifugation (2000xg, 20 min). Particle size was 250nm ± 14 
with a modal size of 160nm. Approximately 50% of all acdEV were released within 
the first 5 hours of apoptosis. 
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